- Corporate
- The share
- Press releases
- Financial calendar
- Financial reports
- Financial reports – ESEF
- Prospectus and material offerings
- Financial presentations
- Corporate governance
- Analyst Coverage
- Code of Conduct
- Environmental Policy
- Code of Conduct for Suppliers
- Privacy policy
- Contact us
- Subscribe
- Thank you
- Error
Conference call on Interim Report
Time: Friday, July 20, 2018 at 2.00 p.m. CET
Registration can preferably be done in advance under the following link:
http://event.onlineseminarsolutions.com/wcc/r/1789895-1/370D12262D8ADF763D4C323D0DAEA7FB
or shortly before time of the conference starts on:
Sweden dial in number: +46 (0)8 5059 6306
USA dial in number: +1 718 873 9077
International dial in number: +44 (0)203 139 4830
Conference name: XVIVO Interim Report Q2 2018, conference ID: 6338175#
Participants from XVIVO Perfusion:
Magnus Nilsson, CEO
Christoffer Rosenblad, CFO
The press release for XVIVO Perfusion’s interim report will be released before the conference call.
Before the conference call, slides will be available at the company web page, www.xvivoperfusion.com/corporate/.
July 12, 2018
Gothenburg
XVIVO Perfusion AB (publ)
For further information please contact:
Christoffer Rosenblad, CFO, +46 735 192159, christoffer.rosenblad@xvivoperfusion.com
Magnus Nilsson, CEO, +46 31-788 21 50, e-post: magnus.nilsson@xvivoperfusion
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.